Literature DB >> 26756569

Assessment of mediators of racial disparities in cervical cancer survival in the United States.

Candace S Sheppard1, Mariam El-Zein1, Agnihotram V Ramanakumar1, Alex Ferenczy2, Eduardo L Franco1.   

Abstract

Cervical cancer (CC) morbidity and mortality have decreased in the United States, but they remain high among black women. We assessed racial disparities in CC mortality, accounting for socioeconomic status (SES). We linked data from the 1988 to 2007 Surveillance Epidemiology and End Results (SEER) database to the US Census. Additional SES information was obtained through linkage with Area Resource Files. We used the Kaplan-Meier method for estimating probabilities following CC diagnosis and Cox proportional hazards regression to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for CC mortality by race. The models were incrementally adjusted for marital status, registry, period, stage, age at diagnosis, histology, treatment, household income, poverty and unemployment rates. We stratified the analyses by disease stage and American state. A total of 44,554 women with CC were identified. Compared to white women, black women had a higher risk of dying from CC; crude and adjusted HRs were 1.41 (CI: 1.34-1.48) and 1.09 (CI: 1.03-1.15), respectively. Corresponding estimates for Hispanic women were 0.85 (CI: 0.80-0.89) and 0.75 (CI: 0.71-0.80). Black women diagnosed at late disease stages had a higher risk of CC death, whereas Hispanic women diagnosed at early and late stages had significantly lower risks. Black CC patients in California experienced poorer survival relative to white women. Conversely, longer CC survival was seen among Hispanic women in California, Georgia and Utah. While crude estimates indicated an increased CC death risk among black women, risks diminished upon adjustment for clinical and sociodemographic characteristics.
© 2016 UICC.

Entities:  

Keywords:  cervical cancer; mortality; racial disparities; socioeconomic status; survival

Mesh:

Year:  2016        PMID: 26756569     DOI: 10.1002/ijc.29996

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  13 in total

1.  Single Marital Status and Infectious Mortality in Women With Cervical Cancer in the United States.

Authors:  Hiroko Machida; Sarah E Eckhardt; Antonio V Castaneda; Erin A Blake; Huyen Q Pham; Lynda D Roman; Koji Matsuo
Journal:  Int J Gynecol Cancer       Date:  2017-10       Impact factor: 3.437

2.  Cervical cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study.

Authors:  Vicki B Benard; Meg Watson; Mona Saraiya; Rhea Harewood; Julie S Townsend; Antoinette M Stroup; Hannah K Weir; Claudia Allemani
Journal:  Cancer       Date:  2017-12-15       Impact factor: 6.860

3.  Uptake of HPV testing and extended cervical cancer screening intervals following cytology alone and Pap/HPV cotesting in women aged 30-65 years.

Authors:  Michelle I Silver; Anne F Rositch; Darcy F Phelan-Emrick; Patti E Gravitt
Journal:  Cancer Causes Control       Date:  2017-11-09       Impact factor: 2.506

4.  Healthcare Disparities in Gynecologic Oncology.

Authors:  Allison Grubbs; Emma L Barber; Dario R Roque
Journal:  Adv Oncol       Date:  2022-05-04

5.  Is there different prognosis between cervical endometrioid adenocarcinoma and ordinary cervical adenocarcinoma in a propensity score matching study based on the surveillance, epidemiology, and end results (SEER) database?

Authors:  Fubin Zhang; Bohong Jin; Hui Yan; Tianhong Zhu; Huiqing Ding; Xueqin Chen; Yutao Guan
Journal:  Transl Cancer Res       Date:  2022-06       Impact factor: 0.496

6.  Is age a prognostic biomarker for survival among women with locally advanced cervical cancer treated with chemoradiation? An NRG Oncology/Gynecologic Oncology Group ancillary data analysis.

Authors:  Kathleen N Moore; James J Java; Katrina N Slaughter; Peter G Rose; Rachelle Lanciano; Paul A DiSilvestro; J Tate Thigpen; Yi-Chun Lee; Krishnansu S Tewari; Junzo Chino; Shelly M Seward; David S Miller; Ritu Salani; David H Moore; Frederick B Stehman
Journal:  Gynecol Oncol       Date:  2016-08-17       Impact factor: 5.482

7.  Mitochondrial DNA ancestry, HPV infection and the risk of cervical cancer in a multiethnic population of northeastern Argentina.

Authors:  Ines Badano; Daiana J Sanabria; Maria E Totaro; Samara Rubinstein; Juan A Gili; Domingo J Liotta; Maria A Picconi; Rodolfo H Campos; Theodore G Schurr
Journal:  PLoS One       Date:  2018-01-12       Impact factor: 3.240

8.  Insurance status and cancer treatment mediate the association between race/ethnicity and cervical cancer survival.

Authors:  Sarah C Markt; Tianyu Tang; Angel M Cronin; Ingrid T Katz; Brooke E Howitt; Neil S Horowitz; Larissa J Lee; Alexi A Wright
Journal:  PLoS One       Date:  2018-02-15       Impact factor: 3.240

9.  Does adenocarcinoma have a worse prognosis than squamous cell carcinoma in patients with cervical cancer? A real-world study with a propensity score matching analysis.

Authors:  Xingxi Pan; Wen Yang; Zhongyong Wen; Feilong Li; Lihua Tong; Wubing Tang
Journal:  J Gynecol Oncol       Date:  2020-11       Impact factor: 4.401

10.  Population-Based Assessment of HPV Genotype-Specific Cervical Cancer Survival: CDC Cancer Registry Sentinel Surveillance System.

Authors:  Benjamin D Hallowell; Mona Saraiya; Trevor D Thompson; Elizabeth R Unger; Charles F Lynch; Tom Tucker; Glenn Copeland; Brenda Y Hernandez; Edward S Peters; Edward Wilkinson; Marc T Goodman
Journal:  JNCI Cancer Spectr       Date:  2018-08-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.